Obesity and Diabetes Research As a multi-receptor agonist, Retatrutide is being investigated for its potential to improve glycemic control and reduce body weight, making it valuable for preclinical studies related to obesity and type 2 diabetes
One of the key differences often highlighted is that tirzepatide works as a dual agonist , while semaglutide works as a single hormone agonist
Retatrutide may help reduce visceral fat, including belly fat, as part of overall fat loss
Overexpression of SLC7A10 in mature white adipocytes was observed to reduce ROS generation and enhanced suppression of SLC7A10 had the opposite impact, suggesting that SLC7A10 supports a beneficial increase in mitochondrial activity within white adipocytes [98]
For people who have B12 deficiencies or malabsorption problems, these supplements are particularly beneficial
Some research has explored whether AHK-Cu may help modulate 5-alpha reductase, the enzyme that converts testosterone to DHT